Give credit where it is due

Hardman & Co

Hardman & Co Report Report Downloads1pm  Plc (LON:OPM)  IFRS9 update highlighted the conservatism in current provisioning, with a minimal impact from adopting the new standard. We have taken the opportunity to review credit and present a range of scenarios (from maintaining current low losses through to a hard recession) and the impact each would have on 1pm’s earnings. The key business message is that, in almost all our scenarios, 2019E profit would be well above the 2017 level. A hard-landing scenario, with losses 1.5x the current IFRS9 worst-case scenario and 4.3x the current level, would see EPS 19% below the 2017 level, and the P/E would be 10x for bottom-of-the-cycle earnings.

IFRS9 impact: On 5 September, 1pm advised that its adoption of IFRS9 would increase provisions from 1.5% to 1.6%. The impact on equity is 0.25%, compared with 1.5% at Orchard Finance, ca 5%-6% at NSF and MCL, 13% at Amigo and 34% at Provident Financial. This reflects 1pm’s historical conservatism.

Credit review: We provide a range of scenarios, and their impact, against 2017 EPS. These include current impairments continuing (EPS up 38%), our base case (EPS up 28%), impairments at the IFRS9 worst-case level (EPS 1% lower) and impairments at 4.3x current levels (1.5x IFRS9 worst-case, EPS down 19%).

Risks: Credit risk is a key factor and is managed by each business unit according to its own specific characteristics, with a group overview of controls. Funding is widely diversified and at least matches the duration of lending. Acquisitions would appear well priced, and delivery of synergies provides earnings upside.

Valuation: We detailed the assumptions in our valuation approaches in our initiation note, “Financing powerhouse: a lunchtime treat”. The GGM indicates 103p and the DDM 73p (DDM normal payout 81p). The 2019E P/E (6.4x) and P/B (0.8x) appear an anomaly with 1pm’s profitability, growth and downside risk.

Investment summary: 1pm Plc offers strong earnings growth, in an attractive market, where management is tightly controlling risk. Targets to more than double the market capitalisation appear credible, with triggers to a re-rating being both fundamental (delivery of earnings growth, proof of cross-selling) and sentiment-driven (payback for management actively engaging the investor community). Profitable, growing companies generally trade well above NAV.

Share on:
Find more news, interviews, share price & company profile here for:

    EDX Medical reports 2025 results and advances in cancer diagnostics

    EDX Medical Group has published its Annual Report for the year ending 31 March 2025, highlighting the development of a new AI-driven prostate cancer test, a £3 million fundraising, expanded European partnerships, and a service agreement with Royal Marsden NHS Foundation Trust.

    Diverse Income Trust reports £257.9m net assets with 4.18% yield

    Diverse Income Trust reported net assets of £257.9 million as of 31 July 2025, with a NAV of 109.08p per share and a share price of 104.00p, reflecting a 4.66% discount. The trust, managed by Gervais Williams and Martin Turner, delivered a 19.42% one-year share price total return and maintains a historic yield of 4.18%.

    Aptamer advances enzyme modulation projects and expands pharma collaboration

    Aptamer Group announced progress on its Optimer® enzyme modulation projects, including a 10-year non-exclusive licensing deal forecast to cover around 15% of annual overheads and further agreements under discussion with global enzyme distributors.

    Structured products fund Volta Finance reports July NAV of €274.2m, performance up 2.5%

    Volta Finance has reported a July net performance of +2.48%, including a dividend of 15.5 cents per share, bringing financial year gains to +13.9%. Net Asset Value stood at €274.2m (€7.49 per share), with strong contributions from CLO equity tranches, which returned +5.2% during the month

    12.2% total return in H1 2025! Global equity income trust GOT delivers

    Global Opportunities Trust reports a 4.0% NAV total return and a 12.2% share price total return for the six months to 30 June 2025, with net assets rising to £110.7 million.

    SAE Renewables rebrands as Ampeak Energy Limited

    Following shareholder approval at its AGM, SAE Renewables (SIMEC Atlantis) has formally changed its name to Ampeak Energy Limited. The move reflects the company’s transition as it advances its flagship AW1 battery storage project, one of the UK’s largest.

      Search

      Search